Teva Pharmaceutical Industries (TEVA) EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, bln rub | ? | 3 213 | 4 610 | 4 528 | 4 105 | 4 267 | 4 179 | ||
Changes by years, y/y, % | +2% | +43% | -2% | -9% | +4% | +6.2% |
Teva Pharmaceutical Industries. EBITDA US GAAP, bln rub
Teva Pharmaceutical Industries. EBITDA US GAAP, changes, %
Teva Pharmaceutical Industries. EBITDA US GAAP, sum by quarters, bln rub
Teva Pharmaceutical Industries (TEVA) EBITDA US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
EBITDA, bln rub | ? | 979.0 | 1 045 | 755.0 | 1 451 | 928.0 | 4 179 | |
Changes by years, y/y, % | -7% | +5% | -28% | +38% | +14% | |||
Changes by quarters, q/q, % | +20% | +7% | -28% | +92% | -36% |